28243978|t|Evaluation of in vitro and in vivo anti-urolithiatic activity of silver nanoparticles containing aqueous leaf extract of Tragia involucrata
28243978|a|The present investigation is focused on exploring the anti-urolithiatic potential of aqueous leaf extract of Tragia involucrata (TIA) and its silver nanoparticles (AgNPs) and to quantify the total phenol, flavonoid, terpenoid and sterol contents present in TIA. Quantification results suggested TIA to be a rich source of phenol, flavonoid and terpenoid and less of sterol content. The AgNPs were synthesized by a simple green method using aqueous extract of T. involucrata. The formation of AgNPs was confirmed through UV spectroscopy, particle size analysis, zeta potential, X-ray diffraction and transmission electron microscopy. The in vitro struvite growth inhibitory activity of the extract was performed using a single gel diffusion method. Samples incorporated with higher concentration of 2% TIA and AgNPs (200 Î¼g mL(-1)) exhibited potent crystal growth inhibitory activity which was further supported by the dissolution of crystals in gel medium. Calcium oxalate stone formation was induced in rats by the oral administration of ethylene glycol in water. Stone formation was assessed by increase in the levels of calcium and phosphorous in the urine and accumulation of nitrogenous substances like urea, creatinine in renal tissues and blood. Prophylactic treatment with TIA and AgNPs showed significant anti-urolithiatic activity with normalization of the mineral contents of the urine and serum samples. Histopathological analysis of the kidney of TIA - and AgNP - treated animals showed no CaOx deposits and a normal architecture of the kidney cells. We conclude that aqueous extract of T. involucrata and its AgNPs has potential for the treatment of patients with recurrent stones.
28243978	0	10	Evaluation	T058	C0220825
28243978	14	22	in vitro	T080	C1533691
28243978	27	34	in vivo	T082	C1515655
28243978	35	61	anti-urolithiatic activity	T169	C0205245
28243978	65	71	silver	T196	C0037125
28243978	72	85	nanoparticles	T073	C1450054
28243978	97	104	aqueous	T080	C0599956
28243978	105	109	leaf	T002	C0242724
28243978	110	117	extract	T167	C2828366
28243978	121	139	Tragia involucrata	T002	C3762783
28243978	152	165	investigation	T058	C0220825
28243978	194	221	anti-urolithiatic potential	T169	C0205245
28243978	225	232	aqueous	T080	C0599956
28243978	233	237	leaf	T002	C0242724
28243978	238	245	extract	T167	C2828366
28243978	249	267	Tragia involucrata	T002	C3762783
28243978	269	272	TIA	T002	C3762783
28243978	282	288	silver	T196	C0037125
28243978	289	302	nanoparticles	T073	C1450054
28243978	304	309	AgNPs	T073	C1450054
28243978	318	326	quantify	T081	C1709793
28243978	331	336	total	T080	C0439810
28243978	337	343	phenol	T109,T121	C0070570
28243978	345	354	flavonoid	T109	C0596577
28243978	356	365	terpenoid	T109,T123	C0039561
28243978	370	376	sterol	T109	C0038323
28243978	377	385	contents	T077	C0456205
28243978	397	400	TIA	T002	C3762783
28243978	402	416	Quantification	T081	C1709793
28243978	417	424	results	T169	C1274040
28243978	435	438	TIA	T002	C3762783
28243978	447	458	rich source	T033	C0449416
28243978	462	468	phenol	T109,T121	C0070570
28243978	470	479	flavonoid	T109	C0596577
28243978	484	493	terpenoid	T109,T123	C0039561
28243978	506	512	sterol	T109	C0038323
28243978	513	520	content	T077	C0456205
28243978	526	531	AgNPs	T073	C1450054
28243978	537	548	synthesized	T052	C1883254
28243978	554	573	simple green method	T057	C2350565
28243978	580	587	aqueous	T080	C0599956
28243978	588	595	extract	T167	C2828366
28243978	599	613	T. involucrata	T002	C3762783
28243978	619	628	formation	T169	C1522492
28243978	632	637	AgNPs	T073	C1450054
28243978	642	651	confirmed	T080	C0521093
28243978	660	675	UV spectroscopy	T059	C0260250
28243978	677	690	particle size	T081	C0030608
28243978	691	699	analysis	T062	C0936012
28243978	701	715	zeta potential	T067	C0597697
28243978	717	734	X-ray diffraction	T059	C0043301
28243978	739	771	transmission electron microscopy	T059	C0678118
28243978	777	785	in vitro	T080	C1533691
28243978	786	794	struvite	T123,T197	C0075338
28243978	795	801	growth	T067	C2911660
28243978	802	812	inhibitory	T052	C3463820
28243978	813	821	activity	T169	C0205177
28243978	829	836	extract	T167	C2828366
28243978	841	850	performed	T169	C0884358
28243978	859	886	single gel diffusion method	T170	C0025663
28243978	921	934	concentration	T081	C0392762
28243978	941	944	TIA	T002	C3762783
28243978	949	954	AgNPs	T073	C1450054
28243978	981	987	potent	T080	C3245505
28243978	988	1002	crystal growth	T070	C1720757
28243978	1003	1013	inhibitory	T052	C3463820
28243978	1014	1022	activity	T169	C0205177
28243978	1058	1069	dissolution	T061	C1285147
28243978	1073	1081	crystals	T122	C1378554
28243978	1085	1088	gel	T122	C0017243
28243978	1089	1095	medium	T167	C1705217
28243978	1097	1118	Calcium oxalate stone	T109	C1983367
28243978	1119	1128	formation	T169	C1522492
28243978	1133	1140	induced	T169	C0205263
28243978	1144	1148	rats	T015	C0034721
28243978	1156	1175	oral administration	T061	C0001563
28243978	1179	1194	ethylene glycol	T109,T131	C0015083
28243978	1198	1203	water	T121,T197	C0043047
28243978	1205	1210	Stone	T031	C0006736
28243978	1211	1220	formation	T169	C1522492
28243978	1225	1233	assessed	T052	C1516048
28243978	1237	1245	increase	T081	C0205217
28243978	1253	1259	levels	T080	C0441889
28243978	1263	1270	calcium	T121,T123,T196	C0006675
28243978	1275	1286	phosphorous	T196	C0031705
28243978	1294	1299	urine	T031	C0042036
28243978	1304	1316	accumulation	T033	C4055506
28243978	1320	1342	nitrogenous substances	T123	C0443444
28243978	1348	1352	urea	T109,T121,T123	C0041942
28243978	1354	1364	creatinine	T109,T123	C0010294
28243978	1368	1381	renal tissues	T024	C1514845
28243978	1386	1391	blood	T031	C0005767
28243978	1393	1415	Prophylactic treatment	T061	C0199176
28243978	1421	1424	TIA	T002	C3762783
28243978	1429	1434	AgNPs	T073	C1450054
28243978	1442	1453	significant	T078	C0750502
28243978	1454	1480	anti-urolithiatic activity	T169	C0205245
28243978	1486	1499	normalization	T062	C1882115
28243978	1507	1514	mineral	T197	C0026162
28243978	1515	1523	contents	T077	C0456205
28243978	1531	1536	urine	T031	C0042036
28243978	1541	1554	serum samples	T031	C1550100
28243978	1556	1573	Histopathological	T169	C0243140
28243978	1574	1582	analysis	T062	C0936012
28243978	1590	1596	kidney	T023	C0022646
28243978	1600	1603	TIA	T002	C3762783
28243978	1610	1614	AgNP	T073	C1450054
28243978	1617	1624	treated	T169	C1522326
28243978	1625	1632	animals	T008	C0003062
28243978	1643	1656	CaOx deposits	T201	C1508136
28243978	1663	1669	normal	T080	C0205307
28243978	1670	1682	architecture	T080	C0205556
28243978	1690	1702	kidney cells	T025	C0553257
28243978	1721	1728	aqueous	T080	C0599956
28243978	1729	1736	extract	T167	C2828366
28243978	1740	1754	T. involucrata	T002	C3762783
28243978	1763	1768	AgNPs	T073	C1450054
28243978	1773	1782	potential	T080	C3245505
28243978	1791	1800	treatment	T169	C0039798
28243978	1804	1812	patients	T101	C0030705
28243978	1818	1827	recurrent	T079	C2945760
28243978	1828	1834	stones	T031	C0006736